Vcanbio Cell & Gene Engineering Corp Ltd (600645) — Financial Flexibility Index
Vcanbio Cell & Gene Engineering Corp Ltd (600645) has a Financial Flexibility Index of 0.08x as of September 2025. Free cash flow of CN¥116.98 Million (operating CF CN¥103.70 Million minus capex CN¥13.28 Million) represents 0% of total liabilities (CN¥1.56 Billion). Check Vcanbio Cell & Gene Engineering Corp Ltd strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Vcanbio Cell & Gene Engineering Corp Ltd Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Vcanbio Cell & Gene Engineering Corp Ltd across 28 annual periods. See Vcanbio Cell & Gene Engineering Corp Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Vcanbio Cell & Gene Engineering Corp Ltd (1998–2025)
Year-by-year free cash flow to debt coverage for Vcanbio Cell & Gene Engineering Corp Ltd. For the full company profile including market capitalisation, see 600645 stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.24x | CN¥363.19 Million | CN¥313.63 Million | CN¥1.54 Billion | ▲ +6.5% |
| 2024 | 0.22x | CN¥352.51 Million | CN¥285.19 Million | CN¥1.59 Billion | ▼ -7.8% |
| 2023 | 0.24x | CN¥387.63 Million | CN¥299.02 Million | CN¥1.61 Billion | ▲ +8.6% |
| 2022 | 0.22x | CN¥361.08 Million | CN¥261.89 Million | CN¥1.63 Billion | ▼ -26.0% |
| 2021 | 0.30x | CN¥448.70 Million | CN¥320.96 Million | CN¥1.50 Billion | ▲ +22.5% |
| 2020 | 0.24x | CN¥336.07 Million | CN¥244.35 Million | CN¥1.38 Billion | ▼ -4.4% |
| 2019 | 0.26x | CN¥364.44 Million | CN¥241.49 Million | CN¥1.43 Billion | ▲ +44.2% |
| 2018 | 0.18x | CN¥258.22 Million | CN¥130.08 Million | CN¥1.46 Billion | ▲ +57.7% |
| 2017 | 0.11x | CN¥153.29 Million | CN¥70.27 Million | CN¥1.37 Billion | ▼ -66.0% |
| 2016 | 0.33x | CN¥413.52 Million | CN¥143.67 Million | CN¥1.25 Billion | ▲ +173.8% |
| 2015 | 0.12x | CN¥136.88 Million | CN¥8.17 Million | CN¥1.13 Billion | ▼ -46.0% |
| 2014 | 0.22x | CN¥281.93 Million | CN¥221.45 Million | CN¥1.26 Billion | ▲ +1.8% |
| 2013 | 0.22x | CN¥181.15 Million | CN¥110.72 Million | CN¥824.89 Million | ▲ +65.9% |
| 2012 | 0.13x | CN¥125.97 Million | CN¥70.41 Million | CN¥951.88 Million | ▼ -38.9% |
| 2011 | 0.22x | CN¥125.26 Million | CN¥110.44 Million | CN¥578.70 Million | ▼ -37.0% |
| 2010 | 0.34x | CN¥181.14 Million | CN¥175.93 Million | CN¥527.56 Million | ▲ +11.2% |
| 2009 | 0.31x | CN¥142.24 Million | CN¥124.92 Million | CN¥460.71 Million | ▼ -14.0% |
| 2008 | 0.36x | CN¥141.92 Million | CN¥121.60 Million | CN¥395.43 Million | ▲ +11.7% |
| 2007 | 0.32x | CN¥129.60 Million | CN¥111.68 Million | CN¥403.23 Million | ▲ +2.6% |
| 2006 | 0.31x | CN¥123.79 Million | CN¥76.12 Million | CN¥395.35 Million | ▼ -28.9% |
| 2005 | 0.44x | CN¥142.24 Million | CN¥84.69 Million | CN¥322.85 Million | ▲ +29.1% |
| 2004 | 0.34x | CN¥84.99 Million | CN¥57.76 Million | CN¥248.95 Million | ▲ +18.9% |
| 2003 | 0.29x | CN¥77.82 Million | CN¥41.74 Million | CN¥271.07 Million | ▲ +294.5% |
| 2002 | 0.07x | CN¥15.25 Million | CN¥-14.75 Million | CN¥209.59 Million | ▲ +218.9% |
| 2001 | -0.06x | CN¥-22.49 Million | CN¥-68.84 Million | CN¥367.31 Million | ▼ -137.1% |
| 2000 | 0.16x | CN¥40.29 Million | CN¥31.71 Million | CN¥244.41 Million | ▲ +213.8% |
| 1999 | 0.05x | CN¥12.88 Million | CN¥4.13 Million | CN¥245.24 Million | ▲ +4.2% |
| 1998 | 0.05x | CN¥12.94 Million | CN¥-32.14 Million | CN¥256.69 Million | — |